The Food and Drug Administration on Thursday authorized booster shots of Pfizer-BioNTech’s COVID-19 vaccine for 16- and 17-year-olds at least six months after their initial doses.
The third dose is identical to the other two. Booster doses are already encouraged for people over 18 who had their previous Pfizer-BioNTech or Moderna vaccines at least six months earlier, or the Johnson & Johnson shot at least two months prior. The U.S. government has pre-purchased enough doses to provide boosters free of charge to anyone who qualifies.
“The booster vaccination increases the level of immunity and dramatically improves protection against COVID-19 in all age groups studied so far,” Ugur Sahin, CEO and co-founder of BioNTech, said in a statement. “It is important to offer everyone a booster, particularly against the background of the newly emerging variants such as Omicron.”
A preliminary study released Wednesday by Pfizer and BioNTech showed only weak protection against the new omicron variant after two shots but suggested protection would be fully restored after a third one.
However Dr. Paul Offit, director of the Vaccine Education Center at Children’s Hospital of Philadelphia, said in a Wednesday call with the media he doesn’t think teenagers need booster shots. They are extremely unlikely to become severely ill from any of the known variants of COVID-19, he said, and males in this age group run a higher risk than older men of myocarditis, a swelling of the heart muscle.
The Biden administration has recommended everyone who is eligible for a booster shot should get one.
– Karen Weintraub
Also in the news:
►The NBA’s Indiana Pacers and Toronto Raptors canceled their Thursday practices, citing an abundance of caution with COVID-19 health and safety protocols.
►African governments might have to resort to vaccine mandates if their citizens don’t hurry to get the increasingly available doses, Africa Centers for Disease Control and Prevention director John Nkengasong said Thursday.
►University of Wisconsin regents voted Thursday to allow student applicants to forego sending in ACT and SAT test scores for another two years. Many colleges across the nation have suspended score submissions because of the pandemic.
►Australia’s Deputy Prime Minister Barnaby Joyce tested positive for the coronavirus while traveling in Washington, D.C. Joyce, who is fully vaccinated, said he has experienced mild symptoms and will remain in isolation while seeking further advice.
►A Massachusetts man who used stolen identities to fraudulently apply for pandemic-related unemployment benefits has been sentenced to more than three years in prison. Wagner Sozi, 33, was also ordered to pay about $110,000 in forfeiture and restitution, the U.S. attorney’s office in Boston announced.
📈Today’s numbers: The U.S. has recorded more than 49.5 million confirmed COVID-19 cases and more than 793,600 deaths, according to Johns Hopkins University data. Global totals: More than 268.2 million cases and 5.2 million deaths. More than 200 million Americans – 60% of the population – are fully vaccinated, according to the CDC.
📘What we’re reading: The COVID-19 pandemic, as a health emergency accompanied by disruption and isolation for families and children, has aggravated mental health issues for both adults and children, research shows.
Keep refreshing this page for the latest news. Want more? Sign up for USA TODAY’s Coronavirus Watch free newsletter to receive updates directly to your inbox and join our Facebook group.
That third shot of the Pfizer-BioNTech COVID-19 vaccine the companies are recommending probably won’t be the last one required to keep the coronavirus at bay.
Variant-specific shots and boosters at least every year will probably be part of the future regimen, according to Pfizer chief scientific officer Mikael Dolsten.
The emergence of the new, highly mutated omicron variant “increases the likelihood that in the future there will be a shift to a variant vaccine,” Dolsten told Bloomberg, adding that the booster shot now being widely promoted will buy time for the development of a vaccine that targets omicron.
That process has already begun, not only by Pfizer but other vaccine makers as well. Early reports out of South Africa, where omicron was first identified, indicate omicron is at least partially able to elude vaccine-induced protection, although most initial infections among the vaccinated have resulted in mild illness.
The latest mutation of the coronavirus, omicron, is making headlines across the nation. But the previous severe mutation, delta, is responsible for the soaring number of infections and hospitalizations across the nation. Dr. Anthony Fauci, President Joe Biden’s chief medical adviser, says omicron, first identified in South Africa last month, “almost certainly is not more severe” than delta.
“There is some suggestion that it might even be less severe,” Fauci told Agence France-Presse this week. “When you look at some of the cohorts that are being followed in South Africa, the ratio between the number of infections and the number of hospitalizations seems to be less than with delta.”
New cases in the U.S. climbed from an average of nearly 95,000 a day on Nov. 22 to almost 119,000 a day this week, and hospitalizations are up 25% from a month ago. The increases are almost entirely from the delta variant, though omicron has been confirmed in at least 21 states and is sure to spread even more.
Deaths are running close to 1,600 a day on average, back up to where they were in October. And the overall U.S. death toll less than two years into the pandemic figures to hit the 800,000 milestone in a matter of days.
Federal health officials on Wednesday authorized a new COVID-19 antibody drug for people with serious health problems or allergies who can’t get adequate protection from vaccination. The AstraZeneca antibody drug cleared by the FDA is the first antibody treatment intended for long-term prevention against COVID-19 infection, rather than a short-term treatment. Beneficiaries will include cancer patients, organ transplant recipients and people taking immune-suppressing drugs for conditions like rheumatoid arthritis. Health experts estimate about 2% to 3% of the U.S. population falls into that group.
“These people still have to shelter in place because they’re at really high risk of severe disease and death,” Dr. David Boulware of the University of Minnesota said ahead of the announcement. “So having this therapy will enable a lot of them to get back to their normal lives.”
Those who refuse to take COVID-19 vaccines are creating a deadly domino effect, a Michigan doctor is warning. They are getting sick, spreading the virus to loved ones and the community, filling hospital beds and using up scarce medical resources, said Dr. Marschall Runge, CEO of Michigan Medicine and dean of the University of Michigan Medical School.
“The bottom line is COVID-19 is not only life-threatening for those who have COVID-19. The surge of COVID-19 is putting others at risk by keeping us from delivering lifesaving care” for everything from heart attacks to cancer to strokes, Runge said in a Wednesday news conference.
The number of Americans fully vaccinated against COVID-19 reached 200 million Wednesday amid a dispiriting holiday-season spike in cases and hospitalizations. Runge said the death rate from cardiovascular disease went up 3% in 2020 after years of steady declines because people delayed treatment. The unvaccinated make up the vast majority of hospitalized COVID-19 patients at Michigan Medicine, Runge said, and every coronavirus patient who is on a ventilator is unvaccinated.
“It’s a dire situation across the state right now,” Runge said. “The state of Michigan reached a record high (number of) hospitalized COVID-19 patients this week – the highest number since the very beginning of the pandemic, now more than a year and a half ago.”
– Kristen Jordan Shamus, Detroit Free Press
Vaccine makers are preparing to update their jabs against the newest coronavirus threat even before it’s clear a change is needed. The World Health Organization has appointed an independent scientific panel to advise on whether the shots need reformulating. Experts doubt today’s shots will become useless but say it’s critical to see how fast companies could produce a reformulated dose and prove it works. Omicron is not likely to be the last worrisome mutation.
Omicron “is pulling the fire alarm. Whether it turns out to be a false alarm, it would be really good to know if we can actually do this – get a new vaccine rolled out and be ready,” said immunologist E. John Wherry of the University of Pennsylvania.
How will the world decide when the pandemic is over? In January 2020, the World Health Organization designated the virus a global health crisis “of international concern.” A couple of months later the WHO — the United Nations’ health agency — described the outbreak as a “pandemic,” reflecting the virus’ spread to nearly every continent. The pandemic may be widely considered over when WHO decides the virus is no longer an emergency of international concern, a designation its expert committee has been reassessing every three months. But when the most acute phases of the crisis ease within countries could vary, experts say.
“There is not going to be one day when someone says, ‘OK, the pandemic is over,’” said Dr. Chris Woods, an infectious disease expert at Duke University.
Data released by the CDC this week could help answer questions about what types of non-COVID deaths increased during the pandemic and which COVID-19 deaths have been misclassified as something else, such as a death from heart disease, stroke or a respiratory illness. Andrew Stokes, an assistant professor of demography and sociology at Boston University’s Department of Global Health, said the new data allows researchers to “drill down” to the county level and see how the pandemic is evolving locally.
“That is unprecedented compared to where we were at just a year ago,” Stokes said. “In a public health emergency, real-time surveillance is critical.”
– Dillon Bergin, Betsy Ladyzhets, Mohar Chatterjee and Derek Kravitz, Brown Institute for Media Innovation
Finland Prime Minister Sanna Marin, one of the world’s youngest elected leaders, apologized this week after facing backlash for spending a night out in Helsinki after she was exposed to COVID-19. Marin explained in a Facebook post on Monday that she was told Saturday that Foreign Affairs Minister Pekka Haavisto had tested positive after being in close contact with her. But she said she was told ministers were not asked to quarantine as long as they had two doses of a COVID-19 vaccine.
So, Marin and her husband met with friends and went out to dinner that night. A gossip magazine published photos of Marin in a nightclub on Saturday and reported that she was dancing until 4 a.m., according to the BBC. The 36-year-old prime minister wrote on Facebook that she left her work phone at home and didn’t immediately receive further guidance recommending she avoid contact with others.
“I should have used better consideration on Saturday night … I’m really sorry,” she said in the post, as translated in multiple reports. She added that she tested negative for the virus Sunday.
– Marina Pitofsky, USA TODAY
Contributing: The Associated Press